ENTITY
Lupin Ltd

Lupin Ltd (LPC IN)

244
Analysis
Health Care • India
Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.
more
•08 Aug 2025 06:39•Broker

HSIE Results Daily: Bajaj Auto, Trent, Lupin, Prestige Estates, Berger Paints...

Bajaj Auto: The company continues to face headwinds in its key export market, NigeriaWhile currency tailwinds should aid the rest of the exports,...

Logo
172 Views
Share
•15 Jul 2025 05:00•Broker

Pharmaceuticals: IPM: 11.5% value and 5% unit growth in Jun’25

As per IQVIA, IPM saw a strong growth for Jun’25 at 11.5% YoY (vs 7% in Apr’25 and FY25, +7% YoY in Jun’24) with 5% YoY growth in units

Logo
191 Views
Share
•10 Jul 2025 19:45•Broker

Pharma and Healthcare: Q1FY26: Steady Revenues, Margins Under Pressure

he India Pharma and Healthcare sector is expected to see steady revenue growth. However, EBITDA margins are expected to show a decline for Q1FY26E

Logo
224 Views
Share
•10 Jul 2025 05:14•Broker

Q1FY26 Earnings Preview - Pharma and Healthcare

We anticipate that pharmaceutical companies within our coverage will collectively demonstrate revenue growth of 9.9% YoY and 0.8% QoQ, along with...

Logo
164 Views
Share
•02 Jul 2025 01:48•Broker

Axis Top Picks for the month of July 2025

Our Top Picks Basket has delivered an impressive return of 336% since its inception (May’20), which stands well above the 175% return delivered by...

Logo
359 Views
Share
x